Germans Trias i Pujol Research Institute (IGTP)

🆕 A new study reveals the underuse of a key drug in patients with treatment-resistant schizophrenia This work by Germans Trias i Pujol Research Institute (IGTP)'s Psychiatry and Mental Health research group, in collaboration with Hospital del Mar-Instituto Hospital del Mar de Investigaciones Médicas (IMIM)'s ETEP group, has been published in the Spanish Journal of Psychiatry and Mental Health. The study highlights the underuse of clozapine in the first two years after the first psychotic episode, despite its proven benefits. The authors emphasize the need for more training and awareness for a broader and earlier implementation of clozapine in clinical practice. Learn more: https://lnkd.in/dq8qB5jY Alba Toll Privat Anna Mane #MentalHealth #Schizophrenia #Research #Clozapine

🆕 The Comparative Medicine and Bioimage Centre of Catalonia #CMCiB celebrated its fifth anniversary yesterday #CMCiB5years The"CMCiB Symposium: 5 years Enabling Pioneering Biomedical Research" at CosmoCaixa was a great success, gathering 200 professionals from the biomedical and medical industries. Key topics included personalised medicine, bioimaging, and robotic surgery. Sara Capdevila, technical director of CMCiB, acknowledged the commitment of the technical staff in supporting research: "The 3Rs are fundamental for the responsible development of science. Our commitment improves the quality of our work and enhances our ability to translate research into clinical practice." Míriam Gironès, business development director of CMCiB, emphasised the centre's potential for collaboration: "Yesterday's symposium highlighted the strong potential for innovation at CMCiB. We are excited to foster relationships that advance research and benefit society." The CMCiB symposium was made possible thanks to the support of Canon Medical Systems Europe, the Faculty of Medicine of Universitat de Vic – Universitat Central de Catalunya (UVic-UCC)-UCC, PFB Serveis Funeraris, Falco Quality, SOGESA, INSTALACIONES INTEGRALES, S.A.U., MATACHANA, and the SECAL, Sociedad Española para las Ciencias del Animal de Laboratorio, in collaboration with Fundación ”la Caixa”. Read more: https://lnkd.in/dfbjdjuY #CMCiB5years #PersonalisedMedicine #Bioimaging #RoboticSurgery

[JOB OFFER] #HiringNow

🆕 Germans Trias i Pujol Research Institute (IGTP), Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS) and eight research institutes publish a guide for inclusive communication in health research. The guide promotes the adoption and acceptance of a language that favors the visibility, equality and representativeness of all people in the field of health research and that avoids those situations in which the language may contain vocabulary or forms that make invisible or discriminate against people, or reproduce traditional stereotypes. ICERCA - Centres de Recerca de Catalunya | Institut d'Investigació Biomèdica de Girona (IDIBGI) | Josep Carreras Leukaemia Research Institute | Instituto Hospital del Mar de Investigaciones Médicas (IMIM) | IRB Barcelona | Institut de Recerca Biomèdica de Lleida Fundació Dr. Pifarré - IRBLLEIDA | Institut de Recerca Sant Pau | Institut d'Investigació i Innovació Parc Taulí (I3PT) and Vall d'Hebron Institute of Oncology (VHIO) Learn more: https://lnkd.in/dUBdy8EB #JoSocHipàtia

🆕 IGTP and DevsHealth join forces to develop new antibiotics against hospital-acquired infections by multi-resistant Staphylococcus aureus 🗣️ "This collaboration will allow us to apply our DeepTech platform to a challenging and important problem, and to accelerate the discovery of new drugs against multi-resistant Staphylococcus aureus infections", said Alfons Nonell-Canals, CEO at DevsHealth. 🗣️ “We believe this partnership will leverage the synergy of our combined expertise and resources, facilitating the discovery of new treatments for a critical public health threat", said Noemí Párraga, researcher at Germans Trias i Pujol Research Institute (IGTP)'s Clinical and Environmental Infectious Diseases Study Group (CEID) and leader of the project. Read more: https://lnkd.in/dzXC6ae5 #DrugResistance #Research #PublicHealth #HospitalAcquiredInfections

[JOB OFFER] #HiringNow 📢  The Clinical Genomics Unit is looking to expand its team with a postdoctoral researcher and a lab technician

🆕 New cellular models of myotonic dystrophy type 1 reflect the clinical diversity of the disease Cellular models used to search for new therapies for myotonic dystrophy type 1 do not usually take into account the diversity of subtypes presented by patients. In a study published in the journal iScience, researchers from Germans Trias i Pujol Research Institute (IGTP), in collaboration with University of Belgrade, Biogipuzkoa and Institut de Myologie, have developed three new models that represent this heterogeneity. Read more: https://lnkd.in/dXYzgyPV #DM1 #MyotonicDystrophyType1 #Research #CellularModels

🆕 As a strategic initiative under IGTP, GCAT - Genomes for life continues to make substantial contributions to public health knowledge. The latest GCAT study, conducted through the #COVICAT initiative and signed by Ximena Goldberg and de Cid Rafael, sheds light on the complex interplay between genetic predispositions and environmental stressors in determining depression risk, especially during the COVID-19 lockdown. Published in Scientific Reports (Springer Nature Group). 📊 Key findings: - Social and behavioural stressors identified as main contributors to depression risk. - Comprehensive risk model explains 16.9% of the variance in depression severity. - Potential buffering effect of environmental stressors on genetic predispositions. 🗣 "The findings from our study highlight the importance of considering both genetic and environmental factors when addressing depression risk," says Rafael de Cid. "This comprehensive approach allows us to develop more effective public health interventions that can mitigate the impact of depression on our communities." 🔗 Learn more: https://lnkd.in/d4P4_8HZ Barcelona Institute for Global Health (ISGlobal) Instituto Hospital del Mar de Investigaciones Médicas (IMIM) Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS) #CIBERESP #CIBERSAM #MentalHealth #COVID19 #PublicHealth

🔵 Innomed Awards drive biomedical innovation Yesterday, the Can Ruti Campus became the epicentre of health innovation with the Innomed Awards ceremony. This event recognised significant advances in biomedicine and reaffirmed our commitment to collaboration among leading research and healthcare institutions. The Innomed programme, which began earlier this year with the support of ITEMAS, the platform of the Instituto de Instituto de Salud Carlos III (ISCIII) for supporting R&D&I in Biomedicine and Health Sciences, is already making a significant impact on collaboration among various innovation units Congratulations to the winners! Market Study and Business Model Awards: 🔹 Ana Piqueras Hinojo (Hospital Universitari Germans Trias i Pujol) 🔹 Laura Belver (Josep Carreras Leukaemia Research Institute) 🔹 Alba Roca (Institut Guttmann) Clinical Regulatory Study Award: 🔹 Mireia Jordà (Germans Trias i Pujol Research Institute (IGTP) Patentability Study Award: 🔹 Carmen Aguilar Gurrieri (IrsiCaixa) Special thanks to our partners Inveniam Group, BHV Partners, GENESIS Biomed, INGECAL, and ZBM Patents & Trademarks for making this possible. Raül Zurita, head of the Innovation Unit at IGTP, shared his vision during the event: "This day not only celebrates achievements in biomedical innovation but also establishes a clear path for its future at the Can Ruti Campus and its surroundings. We have a rich and potent ecosystem that has been driving innovation for some time. This programme has demonstrated that it offers the necessary tools to continue advancing and achieving good results." 🔵 Link to the news, which includes more information about the event, photo album and video of the programme: https://lnkd.in/daYvFHDg Consorci Sanitari del Maresme, Hospital Universitari Germans Trias i Pujol, Institut Català d'Oncologia (ICO), Josep Carreras Leukaemia Research Institute, IrsiCaixa, Institut Guttmann Oriol Iborra Egea, PhD - NIMBLE Diagnostics Alicia Martínez Piñeiro - Time is Brain Alberto Martín Martínez - AIMS-Medical SL #IGTPInnovation #InnomedAwards #BiomedicalInnovation

🔵 SAVE THE DATE Join us for the "CMCiB Symposium: 5 Years Enabling Pioneering Biomedical Research', dedicated to commemorating the achievements in biomedical research and the advances in scientific and technological transfer that have collectively been made possible at Comparative Medicine and Bioimage Centre of Catalonia (#CMCiB). Presented by Pere Renom, biologist and reporter of the Catalan TV program Quèquicom, the event’s main highlights include: ▫ Plenary session: featuring Dr Joao Lima (Johns Hopkins Bloomberg School of Public Health), an internationally acclaimed scientist known for his innovative work in cardiac imaging and image-guided therapies. ▫ Research showcases: hear from our researchers and clients in medtech about breakthroughs in medical imaging, artificial intelligence, infectious diseases, oncological therapies, and more. ▫ Expert roundtable: a dynamic discussion on the role of bioimaging in personalised medicine. ▫ Networking opportunities: connect with peers over coffee and close the day with appetizers and drinks. Event details: 📆 Date: Tuesday, 9 July 📌 Venue: CosmoCaixa Science Museum, Barcelona (Auditorium) 🔸 Language: English Register and check the programme: https://lnkd.in/dmjmuBgA